26 May 2013
Keywords: toyama, mitsubishi, antibiotic, approved, tokyo, japan-headquartered, groups
Article | 07 March 2005
Tokyo, Japan-headquartered groups Toyama Chemical and Mitsubishi Pharma have obtained an additional approval for their novel quinolone antimicrobial agent, pazufloxacin ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.